NCT00242307View on ClinicalTrials.gov

Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

September 30, 2006

Study Completion Date

June 30, 2007

Conditions
Bronchial Asthma
Interventions
DRUG

Roflumilast

Trial Locations (1)

Unknown

Nycomed Japan and Mitsubishi Tanabe Pharma Corporation, Osaka

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
collaborator

Mitsubishi Tanabe Pharma Corporation

INDUSTRY

lead

AstraZeneca

INDUSTRY